00006-5033 Ontruzant - CanMED: NDC

Product NDC:

00006-5033

Brand Name:

Ontruzant

Generic Name:

Trastuzumab

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/1

Packages:

Code: 00006-5033-02

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-5033-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0006-5033-01)

Effective Date: April 15, 2020

Discontinued: Sept. 30, 2023

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox